An Indian company chooses a location for a pharmaceutical factory in the Murmansk region

MURMANSK, September 19 – RIA Novosti. Murmansk region authorities plan to provide full support to the Indian investor’s project to build a pharmaceutical complex and a plant for active pharmaceutical ingredients; It was reported that a land has already been selected for the implementation of the project. ministry Information policy of the region.

On Tuesday, Governor Andrei Chibis held a working meeting with Divesh Kumar, General Director of Indian investor SAFFARM LLC, dedicated to the construction of a pharmaceutical complex in Murmansk. In June, St. As part of the St. Petersburg International Economic Forum, the government of the Murmansk region, the Far Eastern and Arctic Development Company and the SAFFARM company signed a cooperation agreement envisaging the construction of a pharmaceutical complex and a plant. active pharmaceutical ingredients.

“The government of the Murmansk region once again confirms its interest in the development of biotechnologies in our region… The investment project you propose and everything connected with it, including the active participation of our science, seems to us very promising, and we Chibis, whose words were quoted in his message, will provide comprehensive assistance in its implementation” said.

He reminded that during the visit of Deputy Prime Minister of the Russian Federation, Minister of Industry and Trade Denis Manturov, the issue of technology development, including scientific research, was also discussed with the participation of Murmansk Arctic University. SAFFARM LLC General Manager thanked the regional president for his support and emphasized the importance of the project for the Indian side.

“We are ready to move to the practical level – we are currently looking for the most suitable land for the construction of a pharmaceutical complex that will only satisfy, in cooperation with the relevant departments of the government of the Murmansk region. Business and also environmental requirements are important,” Kumar said.

In August, SAFFARM LLC received resident status in the Arctic region of the Russian Federation. It is planned to build a pharmaceutical complex consisting of three blocks with a total area of ​​more than 14 thousand square meters in Murmansk in 2024-2027. The creation of modern high-tech pharmaceutical production is expected to meet domestic demand for antibiotics, vaccines, vitamins, minerals, amino acids, including hormonal and oncological drugs.

Import replacement products will be supplied to public hospitals and pharmacies in Russia and CIS countries. The project is expected to be implemented gradually over three years with a capacity of more than 1.3 billion units of drugs and 1.8 thousand tons of active pharmaceutical ingredients per year and expanded to 6 thousand tons per year. 280 northerners will be employed at the opening of the business.